MedTrace Logo

A Safety Assessment of the iZephyr Hood for NIV in COVID-19 Patients

NCT04904484 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-03-13

No results posted yet for this study

Summary

This study is a safety assessment of the iZephyr hood a novel aerosol removal device in patients receiving non invasive ventilation for COVID-19.

Conditions

  • Aerosol Disease
  • Covid19
  • Noninvasive Ventilation

Interventions

DEVICE

iZephyr hood

Assessment of an aerosol containment device

Sponsors & Collaborators

  • Mercedes AMG PETRONAS Formula One Team

    collaborator UNKNOWN

  • Imperial College London

    collaborator OTHER

  • Imperial College Healthcare NHS Trust

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-06-01
Completion
2025-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04904484 on ClinicalTrials.gov